|
Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients. |
|
|
Employment - Novartis Institutes for BioMedical Research |
Stock and Other Ownership Interests - Novartis |
Patents, Royalties, Other Intellectual Property - Patent Pending |
|
|
Consulting or Advisory Role - Janssen; Jazz Pharmaceuticals; Novartis; Pfizer |
Research Funding - Novartis |
|
|
Consulting or Advisory Role - Novartis |
Research Funding - Novartis |
|
|
Consulting or Advisory Role - Bluebird Bio; Jazz Pharmaceuticals; Novartis; Therakos |
Patents, Royalties, Other Intellectual Property - Viracor Eurofins |
|
|
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis |
Research Funding - Adaptive Biotechnologies |
Travel, Accommodations, Expenses - Medac |
|
|
|
|
|
Consulting or Advisory Role - Novartis |
Speakers' Bureau - Novartis |
Travel, Accommodations, Expenses - Novartis |
|
|
|
Consulting or Advisory Role - Novartis |
Speakers' Bureau - Novartis |
Research Funding - Novartis (Inst) |
|
|
Employment - Novartis Institutes for BioMedical Research |
|
|
|
|
Lida Bubuteishvili-Pacaud |
|
Stock and Other Ownership Interests - Novartis |
|
|
|
Stock and Other Ownership Interests - Novartis |
|
|
|
|
|
Honoraria - Abbvie; Janssen; Novartis |
Research Funding - Abbvie (Inst); Janssen (Inst) |
|
|
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche |
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche |
Research Funding - Gilead Sciences (Inst); Novartis (Inst); Roche (Inst) |
|
|
Honoraria - Amgen; Celgene; Novartis |
Consulting or Advisory Role - Novartis |
Speakers' Bureau - Celgene; Janssen |
Travel, Accommodations, Expenses - Jazz Pharmaceuticals; Novartis |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Celgene; Gilead Sciences; Gilead Sciences; Merck; Nordic Nanovector; Novartis; Pharmacyclics |
Research Funding - Adaptive Biotechnologies (Inst); Celgene (Inst); Gilead Sciences (Inst); Johnson & Johnson (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst) |
|
|
Employment - Cambium Medical Technologies |
Leadership - Cambium Medical Technologies |
Stock and Other Ownership Interests - Cambium Medical Technologies |
Consulting or Advisory Role - Amgen; Celldex; Kalytera Therapeutics; Novartis |
Research Funding - Celldex; Novartis |
Patents, Royalties, Other Intellectual Property - Cambium Medical Technologies |
Travel, Accommodations, Expenses - Amgen; Novartis |
|
|
Consulting or Advisory Role - Lilly; Loxo; Novartis |
Research Funding - Pfizer (Inst) |